Homeβ€ΊSearchβ€ΊMultiple Sclerosis Journal - Experimental, Translational and Clinical

Multiple Sclerosis Journal - Experimental, Translational and Clinical

SAGE Publications Inc. Β· United Kingdom Β· Est. 2003

ISSN2055-2173eISSN2055-2173
SJR Q2βœ“ WOS ESCIβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
88
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† Scopus Q266
βœ“ Corroboration (4 more)+22
Total88
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
15
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (ESCI) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.665
H-Indexi
40
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.678
Total Worksi
591
Total Citationsi
7,221
2yr Mean Citednessi
1.03
Open Impact Factor alternative

Aims & Scope

Subject areas: Clinical Neurology; Neurology (clinical); Cellular and Molecular Neuroscience.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published2003
Annual Volume~ 51 articles / year
StatusActive (last: 2026)
Total Publications591
Publisher OrgSAGE Publishing
OA Since2014
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~15 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

9/12 Β· 75%
βœ…
Do you know the journal / publisher?
SAGE Publications Inc.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2055-2173 / 2055-2173
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
60
985
2019
68
1k
2020
68
902
2021
59
515
2022
48
260
2023
41
94
2024
63
58
2025
43
3
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Neurology (clinical)Q2
Cellular and Molecular NeuroscienceQ3

Subject Classification

Web of Science Categories

Clinical Neurology

Scopus Categories

Neurology (clinical)Cellular and Molecular Neuroscience

Research Topics (OpenAlex)

Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersAmyotrophic Lateral Sclerosis ResearchPolyomavirus and related diseasesSystemic Sclerosis and Related DiseasesSystemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesBalance, Gait, and Falls PreventionCerebral Palsy and Movement DisordersLong-Term Effects of COVID-19

Frequently asked questions about Multiple Sclerosis Journal - Experimental, Translational and Clinical

Is Multiple Sclerosis Journal - Experimental, Translational and Clinical a predatory journal?

PubScope has no integrity flags on record for Multiple Sclerosis Journal - Experimental, Translational and Clinical: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 88/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

Multiple Sclerosis Journal - Experimental, Translational and Clinical is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.03.

Is Multiple Sclerosis Journal - Experimental, Translational and Clinical indexed in Scopus and Web of Science?

Multiple Sclerosis Journal - Experimental, Translational and Clinical is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

Subject areas: Clinical Neurology; Neurology (clinical); Cellular and Molecular Neuroscience.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref